Launched in 1997, Pharmapack is the leading European event for Pharmaceutical Packaging, Drug Delivery, Medical Devices and Machinery. In the past 25+ years, the event has grown from a conference with a small table-top exhibition, to an event hosting 300+ exhibitors and welcoming attendees from 75 different countries.

Advanced Therapies Week has been the epicenter of the cell & gene therapy revolution, a dynamic and must-attend forum where breakthrough technologies and impactful partnerships come to life to transform drug development.

This January, join over 450 industry experts as we dive deep into the most pressing challenges and innovations in contentious IP law.

Across three days of focused discussions and networking, you’ll gain valuable insights into the latest case law, regulatory updates, and strategic litigation approaches, while connecting with key stakeholders who drive the future of life sciences IP.

This prestigious event will bring together industry leaders, experts, and professionals from around the globe to discuss the latest trends, innovations, and best practices in cleanroom design and engineering.

With a new U.S. president, fresh regulations, and shifting deal trends, 2025 is set to be a transformative year for biopharma and healthcare. At Fierce JPM Week 2025, industry leaders will come together to explore what’s next. From market analysis to an examination of evolving regulatory landscapes, this event will provide expert insights into the opportunities and pressing challenges shaping the future of pharma, biotech, and healthcare.

Kick off 2025 and set the tone for the year at SAE Media Group's 17th Annual Pre-Filled Syringes and Injectable Drug Devices Conference will return to London in January to unite leaders from the industry, bringing you the latest advances in the combination product drug delivery space and the chance to collaborate across a 3 day programme.

This premier conference is the largest and most informative health care investment symposium in the industry which connects global industry leaders, emerging fast-growth companies, innovative technology creators and members of the investment community.

Join us at PepTalk, the premier conference dedicated to advancing biotherapeutic discovery and development. With over two decades of experience, PepTalk provides comprehensive programming and innovative solutions that bridge biotherapeutic research and practical application.

Antibody Engineering & Therapeutics is the global meeting place for antibody science, technology and networking, bringing you the latest antibody science, technologies and partners needed to accelerate next generation antibodies towards commercial success. The Antibody Society members are responsible for designing the scientific program and act as the session Chairs.

For over 30 years, renowned academic and industry scientists from around the world have convened to share best practices and scientific results to accelerate antibody research, discovery efforts and clinical programs.

Cell Bio 2024, the joint meeting of the American Society for Cell Biology (ASCB) and European Molecular Biology Organization (EMBO), will showcase a diverse global community of the brightest minds in cell biology. Come network with scientists, present research, explore the exhibit hall, and learn the latest in science and technology focusing on cell biology as the fundamental basis of biology as well as emerging interdisciplinary topics.

The Drug Delivery to the Lungs Conference (DDL) is in it’s 35th year and attracts in excess of 1000 attendees worldwide, including scientists, academics, clinicians, regulators and industry experts. The conference includes a large industry exhibition, supported by over 100 international companies, a scientific poster hall, expert lectures and excellent networking opportunities over the 3-day event. DDL actively supports young scientists by offering free registration for students, Career Development Grants and a variety of awards, recognising their achievements.

The complement community is shifting gear, with more companies than ever targeting alternative complement proteins for their therapies, allowing for a larger range of diseases to be targeted.

With more assets in ophthalmology, neurology, and oncology than ever before, the complement-based therapeutics field has everyone asking the same question: which inhibitor will be the next to harness the complement system for the development of groundbreaking therapies?

From the discovery of new pathways to target to post-approval indication expansion, the immunology landscape is primed to capitalize on the huge strides being taken in achieving efficacy and approving the safety profile of complement-based therapeutics.

Join 100+ complement industry leaders, scientists, and clinicians at the premier, end-to-end 8th Complement-Based Drug Development Summit to shape the future of complement-targeted therapies.

The 7th Annual RNA-Targeted Drug Discovery & Development Summit returns to Boston this December. Increase your knowledge of RNA tertiary structures, delve into innovative preclinical modelling strategies and identify optimal chemical features for advancing specific, efficacious and safe small molecules.

Unite with 100+ RNA Science, Medicinal Chemistry, Structural Biology & Biophysics experts from the likes of AstraZeneca, Sanofi, Novartis, PTC Therapeutics, ReviR Therapeutics, Rgenta Therapeutics, Accent Therapeutics and more at the most comprehensive and definitive event for the community, the 7th RNA-Targeted Drug Discovery & Development Summit, to accomplish faster and smoother translation of RNA targeted therapies towards the clinic.

The 2024 ISPE Pharma 4.0™ and Annex 1 Conference will bring together leading pharmaceutical and biopharmaceutical manufacturers, technology providers, academic scientists, and international regulators to network, share insights, and provide an outlook on digital transformation, automation, and the evolving landscape and future of Pharma 4.0™ supported Aseptic Manufacturing.

The 4th ADC Target Selection Summit has been created for those professionals seeking to develop a first-in-class ADC through innovation in the target.

In an intimate and discussion-focused environment, hone into the complex mechanistic biology around the target to implement advanced computational approaches to screen potential targets, don’t miss this opportunity to place novel targeting as a high priority.

Advances in digital health and connected devices are revolutionizing the parenteral drug delivery landscape. This two-day summit features expert insight into next-generation CP product development, and the complex quality, safety, and regulatory compliance issues facing the industry. Pharma Ed’s Pre-filled Syringes & Injection Devices 2024: Exploring the Future of Parenteral Combination Products provides comprehensive coverage of current and future trends in combination product development for parenteral delivery platforms and devices.

SynbiTECH is the UK’s leading international forum for people engaged in engineering biology (synthetic biology) business, investment, policymaking, science and research.

Running for the fifth time, this major UK synthetic biology business conference will attract more than 400 delegates and speakers, bringing together the best and brightest minds in SynBio, sustainability and business innovation.

Join the 6th Cell Therapy Analytical Development Summit to advance your analytics, accelerate through IND and clinical trials, and achieve regulatory success.

Explore three focused tracks on immunophenotype, cell-based, and molecular assays. Collaborate with industry leaders like Bristol Myers Squibb, Kite Pharma, and Takeda, and gain actionable insights to propel your pipeline forward.

The Personalized Cancer Vaccine Summit (formerly known as the mRNA Cancer Vaccine Summit) returns to Boston for the third year bringing together the top industry players developing individualized approaches across several modalities including mRNA, DNA, peptides, viral, dendritic cell and more to share how they are conquering common challenges, developing novel bioinformatic strategies, and achieving clinical efficacy.

Join the likes of BioNTech, CureVac, Imvax, NousCom and 80+ key stakeholders at the ultimate learning and networking forum to help you and your teams advance your patient-centric pipelines towards the clinic and regulatory approval.

With 650 international participants from 30+ countries, MedFIT is your opportunity to connect with international key innovators in the MedTech, Diagnostic and Digital Health sectors.

As the leading European partnering event, MedFIT provides the ideal environment to help industry players to source early-stage assets, to facilitate the emergence of collaborative projects between big players, public research institutions, start-ups and SMEs, to increase licensing opportunities, to obtain funding and to facilitate market access.

XPOMET © Medicinale is an international, interactive healthtech convention. The event "Numero Uno" took place in Leipzig in spring 2018 and caused a great stir in the healthcare industry. After an electrifying XPOMET 2019 in Berlin, we are back. For the XPOMET 2024 in the Congress Center Leipzig (CCL).

With 2500 attendees, 70 world-class speakers and over 100 industry partners, XPOMET 2024 is the place to be if you want to meet, collaborate and make a real impact in the world of healthcare.

Steered by its prestigious committee, the BioFIT conference programme is shaped to correspond to the interests of every player in the sector and to meet the expectations of its stakeholders, whose sharp minds operate in the fast-paced Life Sciences sector. The 2024 programme is rooted in four custom-made tracks, addressing the right funding sources for early-stage innovation, best practices in academia-industry R&D collaborations, winning ways to nurture early-stage assets and animal health highlights.

Riding the wave of drug delivery innovation, the industry’s definitive 6th CNS Drug Delivery Summit returns to showcase breakthrough progress in receptor-mediated transcytosis, CSF dose escalation, quantifying brain distribution, BBB modeling, CED and FUS technology, emerging modalities including LNPs, and more.

Join 100+ of your industry colleagues from the likes of Roche, Biogen, UCB, JCR, Ionis, Janssen, Eli Lilly, Alector, Novartis, Bristol Myers Squibb, Sanofi, and Takeda as they seek to discover and translate safer, more effective brain delivery technologies to change the trajectory of CNS drug development.

The 2nd Cell Therapy for Autoimmune Disease Summit returns to Philadelphia bigger and better after last year’s explosive debut as the only meeting covering every aspect of bringing cell therapies to the autoimmune space. This is your unmissable opportunity to learn the A-Zs of accelerating your candidates to be the first in the market and finally bring the cure for an autoimmune indication.

RSNA 2024 will center on the bright horizon of radiology and the important role AI plays in empowering radiologists into the future. Make plans to join us in Chicago from Dec. 1–5 as we explore how to intentionally and intelligently build the right connections between people and technology.

We are proud to welcome you to the eighth edition of the Immunotherapies & Innovations for Infectious Diseases Congress (I4ID2024), that will be held in Lyon, France on November 27-28, 2024.

The purpose of this two-day congress is to foster interactions between pharmaceutical industries, research labs, service providers, technology developers, and clinicians, thereby contributing to the development of innovative strategies against infectious diseases in a multidisciplinary approach.

The I4ID2024 will include keynote lectures, pitch talks of new innovative projects, industrial talks from pharmaceutical companies and poster presentations.

Biotech Outsourcing Strategies Events bring together stakeholders in R&D outsourcing to share experience, build existing outsourcing partnerships and forge new buyer/supplier business relationships. BOS is an event where business gets done and where you can be confident of high quality interactions with potential business partners. You will receive a warm welcome from the Bio2Business team in the vibrant and buzzing City of Manchester!

BOS Manchester 2024's scope is primarily development stage CMC outsourcing for both Small Molecules and Biologics, as well as covering Novel Therapeutic Entities.

The event for all pharmaceutical laboratory sectors will take place for the 12th time from 25-27 November 2024 - on site in Düsseldorf/Neuss. The PharmaLab 2024 conferences will cover various topics and lectures on analytics, bioanalytics and microbiology.

Parallel to the conferences, participants will have the opportunity to visit the accompanying trade exhibition. It offers comprehensive information about available products, services and the latest developments around the laboratory.